Reimbursement News
Reimbursement news and insurance coverage updates.
An overwhelming volume of arbitration requests has made it difficult for providers, including labs, to quickly challenge and resolve payment disputes under the law.
Among potential growth opportunities, the firm's new CEO noted hospital lab M&A and STD and cancer testing.
HHS OIG Report Finds Medicare Spending on Lab Tests Increased 17 Percent in 2021
Spending increased to $9.3 billion in 2021, up from $8.0 billion in 2020 and the biggest change in spending since OIG began monitoring payments in 2014.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Lawmakers are still wrangling over whether to include these two key lab industry bills in an end-of-year spending package due to pass next week.